Genetic alterations of the p14ARF-hdm2-p53 regulatory pathway in breast carcinoma

Breast Cancer Research and Treatment

Volumn 65, Issue 3, 2001, Pages 225-232

  Ho, Gay Hui ^a,b   Calvano, Jacqueline E ^a   Bisogna, Maria ^a   Abouezzi, Ziad ^a   Borgen, Patrick I ^a   Cordón Cardó, Carlos ^a   Zee, Kimberly J Van ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Breast cancer; Cell cycle regulation; HDM2; p14ARF; TP53

Indexed keywords

MESSENGER RNA; PROTEIN P53; MDM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN; PROTEIN MDM2; PROTEIN P14ARF;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; EXON; GENE AMPLIFICATION; GENE DELETION; GENE INACTIVATION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; BREAST TUMOR; CARCINOMA; CELL CULTURE; CELL CYCLE; CELL TRANSFORMATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CARCINOMA; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; NUCLEAR PROTEINS; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0035260812     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010686518990     Document Type: Article

References (43)

1. Mutations in p53 as potential molecular markers for human breast cancer
2. Mutations in the p53 gene in primary human breast cancers
3. Prognostic significance of p53 gene alterations in node-negative breast cancer
4. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
5. Mutation detected by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value
6. Relating geno-type and phenotype in breast cancer: An analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations
7. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
8. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53
9. The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses
10. The p53-mdm-2 autoregulatory feedback loop
11. Mdm2 promotes the rapid degradation of p53
12. Regulation of p53 stability by Mdm2
13. p53 mutation and MDM2 amplification in human soft tissue sarcomas
14. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line
15. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth
16. DNA amplifications at 20q 13 and MDM2 define distinct subsets of evolved breast and ovarian tumours
17. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status
18. mdm2 gene alterations and mdm2 protein expression in breast carcinomas
19. ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53
20. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
21. ARF, participates in a regulatory feedback loop with p53 and MDM2
22. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
23. INK4A transcript
24. Complex structure and regulation of the P16 (MSTI) locus
25. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
26. ARF
27. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia
28. Mutations in the p53 gene in male breast cancer
29. Detection of amplified oncogenes by differential polymerase chain reaction
30. MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma
31. Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas
32. Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes
33. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias
34. Structural aspects of the p53 protein in relation to gene evolution
35. Polymorphism at codon 213 within the p53 gene
36. The MDM2 gene amplification database
37. Amplification of a gene encoding a p53-associated protein in human sarcomas
38. The p53-? binding protein MDM2 gene is differentially expressed in human breast carcinoma
39. INK4a gene is frequently lost in small cell lung cancer
40. ARF, and CDK4 in familial melanoma: Analysis of a clinic-based population
41. INK4a exon 1β is wildtype in MCF-7
42. ARF is not detected in hemopoietic human cell lines that abundantly express the alternative β transcript of the p16INK4a/MTS1 gene